IP Library Granted Patent US 11,613,770
Granted Patent B2
US 11,613,770 · App. 16/213,037 · Granted Mar 28, 2023

Compositions and methods for making (R)-reticuline and precursors thereof

Inventors: Peter James Facchini (Calgary, CA); Scott Cameron Farrow (Calgary, CA); Guillaume Arthur Welch Beaudoin (Calgary, CA)
Assignee: ANTHEIA, INC.
C12P17/12A01H1/06C12N9/0006C12N9/1085C12N15/8218C12N15/8243C12Y101/01247C12Y205/01059
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,613,770
App. No.
16/213,037
Granted
Mar 28, 2023
Kind
B2
Abstract

Methods that may be used for the manufacture of the chemical compound (R)-Reticuline and synthesis precursors thereof. Compositions useful for the synthesis (R)-Reticuline and synthesis precursors are also provided.

Claims (16)

1. A method for preparing (R)-Reticuline or an (R)-Reticuline precursor, the method comprising:

(a) introducing into a non-plant cell a chimeric nucleic acid sequence that encodes a polypeptide haying an amino acid sequence that corresponds to at least 85% of the sequence identity to the polypeptide encoded by SEQ ID NO: 322, comprising as operably linked components:

(i) a first nucleic acid sequence encoding CYP450;

(ii) a second nucleic acid sequence encoding AKR; and

(iii) one or more nucleic acid sequence capable of controlling expression in a host cell;

(b) growing the host cell to produce CYP450, AKR, and (R)-Reticuline or the (R)-Reticuline precursor.

2. The method of claim 1 , wherein the non-plant cell is a yeast cell.

3. The method of claim 1 , wherein the non-plant cell is a bacteria cell.

4. The method of claim 1 , wherein the chimeric nucleic acid sequence that encodes a polypeptide having an amino acid sequence that corresponds to at least 90% of the sequence identity to the polypeptide encoded by SEQ ID NO: 322.

5. The method of claim 1 , wherein the chimeric nucleic acid sequence that encodes a polypeptide having an amino acid sequence that corresponds to at least 95% of the sequence identity to the polypeptide encoded by SEQ ID NO: 322.

6. The method of claim 1 , wherein the host cell produces (S)-Reticuline.

7. The method of claim 1 , wherein the host cell produces (R)-Reticuline.

8. The method of claim 1 , wherein the host cell produces at least one compound selected from the group consisting of (S)-Coclaurine, (S)-N-Methylcoclaurine, (S)-3′-Hydroxy-N-methylcoclaurine, (R)-N-Methylcoclaurine, (R)-3′-Hydroxy-N-methylcoclaurine, and (S)-Reticuline.

9. The method of claim 1 , wherein the host cell produces at least one (R)-Reticuline precursor selected from the group consisting of (R)-N-Methylcoclaurine or (R)-3′-Hydroxy-N-methylcoclaurine.

10. The method of claim 1 , wherein growing the host cell comprises:

culturing the host cell in a cellular growth medium, wherein the cellular growth medium comprises at least one of (S)-Norcoclaurine, (S)--N-Methylnorcoclaurine, (S)-Norlaudanosaline, (S)--N-Methylnorlaudanosaline, (S)-Coclaurine, (S)-N-Methylcoclaurine, (S)-3′-Hydroxycoclaurine, (S)-3′-Hydroxy-N-methylcoclaurine, (S)-Higenamine, (S)--N -Methylhigenamine, (S)-Laudanosoline, (S)-Norreticuline, and (S)-Orientaline.

Assignments (7)
SECURITY INTEREST Recorded Aug 29, 2025
From: ANTHEIA, INC.
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 072750/0812 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2025
From: WILLOW BIOSCIENCES, INC.
To: ANTHEIA, INC.
Reel/Frame 070785/0704 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2021
From: ELESZTO GENETIKA, INC.
To: ANTHEIA, INC.
Reel/Frame 055485/0062 →
MERGER Recorded Oct 22, 2020
From: WILLOW BIOSCIENCES, INC.; EPIMERON INCORPORATED; VINDOLON INCORPORATED; SERTURNER CORPORATION
To: WILLOW BIOSCIENCES, INC.
Reel/Frame 054139/0229 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2020
From: WILLOW BIOSCIENCES, INC.
To: ELESZTO GENETIKA INC.
Reel/Frame 054082/0973 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 7, 2018
From: FACCHINI, PETER J.; FARROW, SCOTT; BEAUDOIN, GUILLAUME
To: UTI LIMITED PARTNERSHIP
Reel/Frame 047706/0863 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 7, 2018
From: UTI LIMITED PARTNERSHIP
To: EPIMERON INC.
Reel/Frame 047706/0879 →
Continuity (4)
Division 15101474
Provisional Application 61911759 · Dec 4, 2013
Provisional Application 62050399 · Sep 15, 2014
Related Publication 20190241919A1 · Aug 8, 2019